BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33858692)

  • 1. Impact of systemic to topical steroids switch on the outcome of drug reaction with eosinophilia and systemic symptoms (DRESS): A monocenter retrospective study of 20 cases.
    Brin C; Bernigaud C; Hua C; Duong TA; Gaudin O; Colin A; de Prost N; Wolkenstein P; Chosidow O; Ingen-Housz-Oro S
    Ann Dermatol Venereol; 2021 Sep; 148(3):168-171. PubMed ID: 33858692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic management of DRESS: a retrospective study of 38 cases.
    Funck-Brentano E; Duong TA; Bouvresse S; Bagot M; Wolkenstein P; Roujeau JC; Chosidow O; Valeyrie-Allanore L
    J Am Acad Dermatol; 2015 Feb; 72(2):246-52. PubMed ID: 25592341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug reaction with eosinophilia and systemic symptoms: A single center descriptive observational study.
    Sandhu S; Neema S; Vashisht D; Venugopal R; Sengupta P; Radhakrishnan S
    Dermatol Ther; 2021 Jan; 34(1):e14670. PubMed ID: 33314590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of add-on therapy with intravenous immunoglobulin in steroid hyporesponsive DRESS syndrome.
    Sim DW; Yu J; Koh YI
    Clin Transl Sci; 2022 Mar; 15(3):782-788. PubMed ID: 34796665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome.
    Rubin L; Talmon A; Ribak Y; Kessler A; Martin Y; Haran TK; Shamriz O; Adini I; Tal Y
    Front Immunol; 2023; 14():1134178. PubMed ID: 37187735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug reaction with eosinophilia and systemic symptoms (DRESS): A tertiary care centre retrospective study.
    Del Pozzo-Magaña BR; Rieder MJ; Garcia-Bournissen F; Lazo-Langner A
    Br J Clin Pharmacol; 2022 Sep; 88(9):4134-4141. PubMed ID: 35421262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral rashes mimicking drug reaction with eosinophilia and systemic symptoms syndrome in children after β-lactams intake: a diagnostic challenge.
    Dondi A; Parladori R; Mori F; Liccioli G; Bassi A; Lanari M; Patrizi A; Neri I
    Eur J Pediatr; 2021 Jul; 180(7):2327-2332. PubMed ID: 33686529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Versus Topical Corticosteroids in the Treatment of DRESS: A Retrospective Cohort Study Followed by a Meta-Analysis.
    Lian BS; Ha JH; Sultana R; Chan LCE; Choo KJL; Yeo YW; Lee HY
    Am J Clin Dermatol; 2023 Jul; 24(4):637-647. PubMed ID: 37133714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric drug reaction with eosinophilia and systemic symptoms: A systematic review of the literature, with a focus on relapsing cases.
    Afiouni R; Zeinaty P; Kechichian E; Zoghaib S; Matar S; Helou-Mallat J; Tomb R
    Pediatr Dermatol; 2021 Jan; 38(1):125-131. PubMed ID: 33155729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a study of 25 patients in Korea.
    Lee JY; Lee SY; Hahm JE; Ha JW; Kim CW; Kim SS
    Int J Dermatol; 2017 Sep; 56(9):944-951. PubMed ID: 28718873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine as an alternative immunosuppressant for steroid-resistant drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
    Tan K; Testro A
    BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36944441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling the complexities of drug reaction with eosinophilia and systemic symptoms (DRESS): Insights into clinical, laboratory, and histopathologic features of a case series from an Italian tertiary center.
    Schroeder JW; Napoli C; Caputo V; Bonoldi E; Rongioletti F
    Clin Dermatol; 2023; 41(6):721-728. PubMed ID: 37730074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Series of 49 French Pediatric Cases.
    Bedouelle E; Ben Said B; Tetart F; Milpied B; Welfringer-Morin A; Maruani A; Catteau B; Dezoteux F; Staumont-Sallé D; Mazereeuw-Hautier J; Abasq C; Chiaverini C; Delaunay J; Mallet S; Sterling B; Puzenat E; Raynal M; Collet E; Bernier C;
    J Allergy Clin Immunol Pract; 2022 Jan; 10(1):267-274.e5. PubMed ID: 34332174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management and treatment outcome of DRESS patients in Europe: An international multicentre retrospective study of 141 cases.
    Kridin K; Brüggen MC; Walsh S; Bensaid B; Ranki A; Oppel E; Meyersburg D; Chua SL; Seeli C; Sandberg H; French LE; Vorobyev A; Ingen-Housz-Oro S
    J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):753-762. PubMed ID: 36479739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paediatric case series of drug reaction with eosinophilia and systemic symptoms (DRESS): 12-year experience at a single referral centre in Hong Kong and the first reported use of infliximab.
    Chua GT; Rosa Duque JS; Chong PCY; Lee PPW; Lau YL; Ho MHK
    Eur Ann Allergy Clin Immunol; 2018 Nov; 50(6):273-276. PubMed ID: 29384118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand.
    Hiransuthikul A; Rattananupong T; Klaewsongkram J; Rerknimitr P; Pongprutthipan M; Ruxrungtham K
    Allergol Int; 2016 Oct; 65(4):432-438. PubMed ID: 27134114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases.
    de Filippis R; Kane JM; Kuzo N; Spina E; De Sarro G; de Leon J; De Fazio P; Schoretsanitis G
    Eur Neuropsychopharmacol; 2022 Jul; 60():25-37. PubMed ID: 35635994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hair loss after drug reaction with eosinophilia and systemic symptoms (DRESS): A multicentric retrospective case series.
    Lee JW; Yu DA; Cho S; Youn SW; Kwon O
    J Dermatol; 2023 Jun; 50(6):814-819. PubMed ID: 36651019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective study of DRESS - drug reaction with eosinophilia and systemic symptoms.
    Mehrholz D; Urban AE; Herstowska M; Nowicki R; Cubała W; Barańska-Rybak W
    Psychiatr Pol; 2017 Dec; 51(6):1079-1093. PubMed ID: 29432504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation into the avoidability of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
    Danjuma MI; Naseralallah LMA; AbouJabal B; Mohamed MF; Abubeker IY; Jabbar LA; Elzouki A
    Sci Rep; 2021 Sep; 11(1):17887. PubMed ID: 34504198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.